$ANIP
ANI Pharmaceuticals Inc Stock $anip

$anip Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000114420416083848 Filed on February 23, 2016

Income Statement

Concept	2015 Q4	2014 Q4	2014 Q3
Revenue	$18.04M	$21.04M	$17.39M
YoY Change	-14.27%	99.78%	121.89%
Cost Of Revenue	$3.540M	$3.670M	$3.061M
YoY Change	-3.54%	26.12%	12.95%
Gross Profit	$14.50M	$17.36M	$14.33M
YoY Change	-16.47%	127.82%	179.48%
Gross Profit Margin	80.4%	82.52%	82.39%
Selling, General & Admin	$5.460M	$4.740M	$4.057M
YoY Change	15.19%	48.13%	16.58%
% of Gross Profit	37.66%	27.3%	28.32%
Research & Development	$660.0K	$570.0K	$883.0K
YoY Change	15.79%	9.62%	94.49%
% of Gross Profit	4.55%	3.28%	6.16%
Depreciation & Amortization	$2.110M	$1.280M	$1.187M
YoY Change	64.84%	190.91%	210.73%
% of Gross Profit	14.55%	7.37%	8.29%
Operating Expenses	$8.230M	$6.600M	$4.940M
YoY Change	24.7%	58.65%	25.57%
Operating Profit	$6.268M	$10.77M	$8.199M
YoY Change	-41.81%	211.33%	912.22%
Interest Expense	-$2.770M	-$800.0K	$10.00K
YoY Change	246.25%
% of Operating Profit	-44.19%	-7.43%	0.12%
Other Income/Expense, Net	$0.00	$90.00K	$82.00K
YoY Change	-100.0%	200.0%	-44.59%
Pretax Income	$3.500M	$10.06M	$8.291M
YoY Change	-65.21%	188.25%	765.45%
Income Tax	$630.0K	-$10.95M	$1.545M
% Of Pretax Income	18.0%	-108.85%	18.63%
Net Earnings	$2.880M	$21.01M	$6.746M
YoY Change	-86.29%	512.54%	466.41%
Net Earnings / Revenue	15.97%	99.87%	38.8%
Basic Earnings Per Share	$0.25	$1.85	$0.59
Diluted Earnings Per Share	$0.25	$1.82	$0.59
COMMON SHARES
Basic Shares Outstanding			11.24M shares
Diluted Shares Outstanding			11.30M shares

Balance Sheet

Concept	2015 Q4	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$154.7M	$169.0M	$35.10M
YoY Change	-8.46%	1422.52%	222.02%
Cash & Equivalents	$154.7M	$169.0M	$35.05M
Short-Term Investments
Other Short-Term Assets	$1.500M	$1.100M	$600.0K
YoY Change	36.36%	83.33%	-79.31%
Inventory	$13.39M	$7.518M	$7.346M
Prepaid Expenses	$1.453M	$1.139M	$599.0K
Receivables	$21.93M	$17.30M	$14.57M
Other Receivables	$1.200M	$0.00	$0.00
Total Short-Term Assets	$192.6M	$195.0M	$57.57M
YoY Change	-1.23%	603.53%	120.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.131M	$5.223M	$5.046M
YoY Change	36.53%	15.12%	8.74%
Goodwill	$1.838M	$1.838M	$1.838M
YoY Change	0.0%	0.0%	-0.02%
Intangibles	$66.40M	$42.07M	$43.19M
YoY Change	57.84%	304.14%	303.16%
Long-Term Investments
YoY Change
Other Assets	$17.30M	$15.40M
YoY Change	12.34%
Total Long-Term Assets	$92.68M	$68.72M	$50.07M
YoY Change	34.87%	309.43%	191.27%
TOTAL ASSETS
Total Short-Term Assets	$192.6M	$195.0M	$57.57M
Total Long-Term Assets	$92.68M	$68.72M	$50.07M
Total Assets	$285.3M	$263.7M	$107.6M
YoY Change	8.17%	492.6%	148.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.066M	$2.654M	$3.059M
YoY Change	-22.16%	85.72%	46.58%
Accrued Expenses	$617.0K	$1.269M	$3.888M
YoY Change	-51.38%	-4.3%	190.54%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.76M	$13.23M	$8.145M
YoY Change	-11.16%	274.02%	23.46%
LONG-TERM LIABILITIES
Long-Term Debt	$113.4M	$106.5M	$0.00
YoY Change	6.48%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$113.4M	$106.5M	$0.00
YoY Change	6.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.76M	$13.23M	$8.145M
Total Long-Term Liabilities	$113.4M	$106.5M	$0.00
Total Liabilities	$125.2M	$119.8M	$8.100M
YoY Change	4.52%	3285.33%	22.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.350M	-$19.73M	-$40.73M
YoY Change	-77.95%	-59.31%	-21.53%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Treasury Stock Shares		0.000 shares	0.000 shares
Shareholders Equity	$160.1M	$139.8M	$99.49M
YoY Change
Total Liabilities & Shareholders Equity	$285.3M	$259.6M	$107.6M
YoY Change	9.9%	483.28%	148.67%

Cashflow Statement

Concept	2015 Q4	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	$2.880M	$21.01M	$6.746M
YoY Change	-86.29%	512.54%	466.41%
Depreciation, Depletion And Amortization	$2.110M	$1.280M	$1.187M
YoY Change	64.84%	190.91%	210.73%
Cash From Operating Activities	$4.700M	$10.74M	$4.160M
YoY Change	-56.24%	-475.52%	-355.21%
INVESTING ACTIVITIES
Capital Expenditures	-$1.100M	-$340.0K	-$410.0K
YoY Change	223.53%	1033.33%	1266.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$22.11M
YoY Change		-100.0%
Cash From Investing Activities	-$1.100M	-$330.0K	-$22.53M
YoY Change	233.33%	-114.8%	75000.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	180.0K	123.6M	460.0K
YoY Change	-99.85%	15156.79%
NET CHANGE
Cash From Operating Activities	4.700M	10.74M	4.160M
Cash From Investing Activities	-1.100M	-330.0K	-22.53M
Cash From Financing Activities	180.0K	123.6M	460.0K
Net Change In Cash	3.780M	134.0M	-17.91M
YoY Change	-97.18%	74338.89%	978.92%
FREE CASH FLOW
Cash From Operating Activities	$4.700M	$10.74M	$4.160M
Capital Expenditures	-$1.100M	-$340.0K	-$410.0K
Free Cash Flow	$5.800M	$11.08M	$4.570M
YoY Change	-47.65%	-491.52%	-385.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1453000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	192583000	USD
CY2015Q2	dei	Entity Public Float EntityPublicFloat	526800000	USD
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Trading Symbol TradingSymbol	ANIP
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	154684000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169037000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21932000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17297000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	13387000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	7518000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	559000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4635000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4784000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5869000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3468000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	314000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	898000	USD
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-11008000	USD
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-787000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	20006000	USD
CY2015	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4312000	USD
CY2014	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	252000	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6043000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	194991000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7131000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5223000	USD
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1127000	USD
CY2014Q4	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1139000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3878000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164431000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	159509000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4350000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19725000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	160082000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	139785000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285265000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259558000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	125183000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	119773000	USD
CY2015Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	113427000	USD
CY2014Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	106540000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	15375000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	28747000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	3856000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	3423000	USD
CY2015	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1877000	USD
CY2014	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-14459000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6831000	USD
CY2014	anip	Increase Decrease Accrued Medicaid Rebates IncreaseDecreaseAccruedMedicaidRebates	2011000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1157000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1651000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30500000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	34634000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2183000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1120000	USD
CY2015	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	0	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	558000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1027000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	225000	USD
CY2015	anip	Increase Decrease In Accrued Compensation Liabilities IncreaseDecreaseInAccruedCompensationLiabilities	-160000	USD
CY2014	anip	Increase Decrease In Accrued Compensation Liabilities IncreaseDecreaseInAccruedCompensationLiabilities	575000	USD
CY2015	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-5380000	USD
CY2014	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	4233000	USD
CY2015	anip	Increase Decrease Accrued Medicaid Rebates IncreaseDecreaseAccruedMedicaidRebates	2367000	USD
CY2014	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	46680000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	819000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	819000	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	750000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	360000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	784000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-14353000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	157932000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11105000	USD
CY2015	us-gaap	Interest Paid InterestPaid	4205000	USD
CY2014	us-gaap	Interest Paid InterestPaid	0	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13255000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	147000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	439000	USD
CY2014	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-40000	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	36000	USD
CY2013	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1110000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7081000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	708000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	188000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-565000	USD
CY2013	anip	Increase Decrease In Accrued Compensation Liabilities IncreaseDecreaseInAccruedCompensationLiabilities	-2854000	USD
CY2013	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	20000	USD
CY2013	anip	Increase Decrease Accrued Medicaid Rebates IncreaseDecreaseAccruedMedicaidRebates	72000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-67000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	191000	USD
CY2013	us-gaap	Proceeds From Repurchase Of Equity ProceedsFromRepurchaseOfEquity	0	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	809000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11094000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11000	USD
CY2013	us-gaap	Interest Paid InterestPaid	250000	USD
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-467000	USD
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27016000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	113427000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015	us-gaap	Revenues Revenues	76322000	USD
CY2014	us-gaap	Revenues Revenues	55970000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2013	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	143750000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	143750000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	33059000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	106540000	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	489000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4450000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3794000	USD
CY2013	us-gaap	Revenues Revenues	30082000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	12692000	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	11473000	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	9974000	USD
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	56000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6200000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66397000	USD
CY2015	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.15	pure
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	606000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	702000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	13586000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	8708000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1666667	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1666667	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2874000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2678000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1712000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21156000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17935000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16388000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	43622000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	35964000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	29184000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	32700000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	41000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	160000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21733000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19379000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	126000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6358000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9368000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-305000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
CY2015	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	0	USD
CY2014	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	0	USD
CY2013	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	-195000	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15375000	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4975000	USD
CY2015	anip	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	15375000	USD
CY2014	anip	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	28747000	USD
CY2013	anip	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	-4869000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.34
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.61
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.96
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.34
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.61
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11370	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10941	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5071	shares
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.32
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.59
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.96
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.32
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.59
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11557	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11053	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5071	shares
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	38000	USD
CY2015	anip	Non Cash Compensation Relating To Business Combination NonCashCompensationRelatingToBusinessCombination	0	USD
CY2014	anip	Non Cash Compensation Relating To Business Combination NonCashCompensationRelatingToBusinessCombination	0	USD
CY2013	anip	Non Cash Compensation Relating To Business Combination NonCashCompensationRelatingToBusinessCombination	4418000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	17264000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	22033000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5289000	USD
CY2015	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	USD
CY2013	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-195000	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17264000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22033000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5484000	USD
CY2015	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	0	USD
CY2014	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	0	USD
CY2013	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	18198000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2260000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-32683000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-35754000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	20267000	USD
CY2015	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2014	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	138243000	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2015	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	0	USD
CY2014	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	15623000	USD
CY2013	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	0	USD
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-4065000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	113000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	433000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1066000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	171653000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3689000	USD
CY2015	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2014	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	40034000	USD
CY2015	anip	Cancellation Of Redeemable Convertible Preferred And Common Stock Value CancellationOfRedeemableConvertiblePreferredAndCommonStockValue	0	USD
CY2014	anip	Cancellation Of Redeemable Convertible Preferred And Common Stock Value CancellationOfRedeemableConvertiblePreferredAndCommonStockValue	0	USD
CY2013	anip	Cancellation Of Redeemable Convertible Preferred And Common Stock Value CancellationOfRedeemableConvertiblePreferredAndCommonStockValue	53726000	USD
CY2015	anip	Acquired Non Cash Net Assets AcquiredNonCashNetAssets	0	USD
CY2014	anip	Acquired Non Cash Net Assets AcquiredNonCashNetAssets	0	USD
CY2013	anip	Acquired Non Cash Net Assets AcquiredNonCashNetAssets	11597000	USD
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4975000	USD
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><strong>Organization and Business</strong></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">ANI Pharmaceuticals, Inc. and its consolidated subsidiaries (together, “ANI,” the “Company,” “we,” “us,” or “our”) is a specialty pharmaceutical company, developing and marketing generic and branded prescription products. ANI was organized as a Delaware corporation in April 2001. At our two facilities located in Baudette, Minnesota, which have a combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, we manufacture oral solid dose products, as well as liquids and topicals, including those that must be manufactured in a fully contained environment due to their potency. We also perform contract manufacturing for other pharmaceutical companies.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On June 19, 2013, BioSante Pharmaceuticals, Inc. (“BioSante”) acquired ANIP Acquisition Company (“ANIP”) in an all-stock, tax-free reorganization (the “Merger”) (Note 2), in which ANIP became a wholly-owned subsidiary of BioSante. BioSante was renamed ANI Pharmaceuticals, Inc. The Merger was accounted for as a reverse acquisition pursuant to which ANIP was considered the acquiring entity for accounting purposes. As such, ANIP's historical results of operations replace BioSante's historical results of operations for all periods prior to the Merger. The results of operations of both companies are included in our consolidated financial statements for all periods after completion of the Merger.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 22.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Our operations are subject to certain risks and uncertainties including, among others, current and potential competitors with greater resources, dependence on significant customers, lack of operating history and uncertainty of future profitability and possible fluctuations in financial results. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and satisfaction of liabilities in the ordinary course of business. The propriety of using the going-concern basis is dependent upon, among other things, the achievement of future profitable operations, the ability to generate sufficient cash from operations, and potential other funding sources, including cash on hand, to meet our obligations as they become due. <font style="FONT-SIZE: 10pt">We believe the going-concern basis is appropriate for the accompanying consolidated financial statements based on our current operating plan and business strategy for the next 12 months.</font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3423000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3856000	USD
CY2013	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	29795000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36000	USD
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><strong>Use of Estimates</strong></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, Medicaid rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, deferred taxes and valuation allowance, and the depreciable lives of long-lived assets. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><strong>Credit Concentration</strong></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Our customers are primarily wholesale distributors, chain drug stores, group purchasing organizations, and other pharmaceutical companies.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the year ended December 31, 2015, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 26</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>% of net revenues, respectively. As of December 31, 2015, accounts receivable from these customers totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 73</font>% of net accounts receivable. During the year ended December 31, 2014, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 30</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14</font>% of net revenues, respectively. During the year ended December 31, 2013, three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 27</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>%, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenues, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	anip	Convertible Preferred Stock Cancelled ConvertiblePreferredStockCancelled	53726000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-42715000	USD
CY2013	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	4975000	USD
CY2013	anip	Adjustments To Additional Paid In Capital Non Cash Compensation Relating To Business Combination AdjustmentsToAdditionalPaidInCapitalNonCashCompensationRelatingToBusinessCombination	4418000	USD
CY2015Q4	anip	Fdic Guaranteed Amount FdicGuaranteedAmount	250000	USD
CY2015Q4	anip	Chargebacks And Other Accruals As Percent Of Gross Revenue ChargebacksAndOtherAccrualsAsPercentOfGrossRevenue	0.5	pure
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3900000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3400000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	36000	USD
CY2015Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.030	pure
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	433000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	113000	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	809000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	40962000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	46680000	USD
CY2014	anip	Embedded Derivative Bifurcated Amount Reclassified To Stockholders Equity Net Of Deferred Tax Asset Liability EmbeddedDerivativeBifurcatedAmountReclassifiedToStockholdersEquityNetOfDeferredTaxAssetLiability	20195000	USD
CY2014	anip	Net Adjustments To Additional Paid In Capital Bond Hedge Acquired Warrant Issued Net Of Deferred Tax Asset Liability NetAdjustmentsToAdditionalPaidInCapitalBondHedgeAcquiredWarrantIssuedNetOfDeferredTaxAssetLiability	-2575000	USD
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	750000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	819000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	819000	USD
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2015	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	784000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	360000	USD
CY2015	us-gaap	Interest Expense Debt InterestExpenseDebt	11143000	USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	811000	USD
CY2013Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	7088000	USD
CY2013Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	29795000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10192000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5056000	USD
CY2015Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	998000	USD
CY2014Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	794000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	456000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	411000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1897000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1368000	USD
CY2015Q4	us-gaap	Inventory Gross InventoryGross	13543000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	7629000	USD
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	156000	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	111000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11581000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9017000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	76498000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45999000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10101000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3932000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7578000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7578000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7578000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7578000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7578000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	28507000	USD
CY2013Q4	anip	Intangible Asset Purchase Agreement Amount IntangibleAssetPurchaseAgreementAmount	12500000	USD
CY2014Q1	anip	Intangible Asset Purchase Agreement Payment IntangibleAssetPurchaseAgreementPayment	4000000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0172	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.550	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	55000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	46000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	31000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	132000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	74000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	70000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	36000	USD
CY2013	anip	Monitoring And Advisory Fee MonitoringAndAdvisoryFee	500000	USD
CY2013	anip	Monitoring And Advisory Fee In Conjunction With Business Combination MonitoringAndAdvisoryFeeInConjunctionWithBusinessCombination	400000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2267000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	414000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16726000	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	414000	USD
CY2015	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2015	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	6358000	USD
CY2014	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	-9368000	USD
CY2013	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	58000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.021	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.001	pure
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7264000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4034000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	611000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	273000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	0	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7875000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4307000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1139000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1468000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2113000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	635000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-409000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	154000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-221000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1877000	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	2.459	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.865	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3.004	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.016	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.012	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.346	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.017	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.040	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.027	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.007	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.293	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.484	pure
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15290000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28588000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4869000	USD
CY2015	anip	Gain On Discontinued Operations Allocated To Common Shares Basic GainOnDiscontinuedOperationsAllocatedToCommonSharesBasic	0	USD
CY2014	anip	Gain On Discontinued Operations Allocated To Common Shares Basic GainOnDiscontinuedOperationsAllocatedToCommonSharesBasic	0	USD
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.161	pure
CY2013	anip	Gain On Discontinued Operations Allocated To Common Shares Basic GainOnDiscontinuedOperationsAllocatedToCommonSharesBasic	194000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2153000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2149000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	12243000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Hedging Transactions DeferredTaxAssetsHedgingTransactions	12677000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	2945000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	1107000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7938000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11798000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1149000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	674000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28203000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29023000	USD
CY2015Q4	anip	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	700000	USD
CY2014Q4	anip	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	587000	USD
CY2015Q4	anip	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	10029000	USD
CY2014Q4	anip	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	11892000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	467000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	16000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	496000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	10745000	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13442000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17316000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	15439000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	15291000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28589000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4869000	USD
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	21700000	USD
CY2015	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	approximately $11.3 million per year
CY2014	anip	Gain On Discontinued Operations Allocated To Common Shares Diluted GainOnDiscontinuedOperationsAllocatedToCommonSharesDiluted	0	USD
CY2013	anip	Gain On Discontinued Operations Allocated To Common Shares Diluted GainOnDiscontinuedOperationsAllocatedToCommonSharesDiluted	193000	USD
CY2015	anip	Gain On Discontinued Operations Allocated To Common Shares Diluted GainOnDiscontinuedOperationsAllocatedToCommonSharesDiluted	0	USD
CY2015Q1	us-gaap	Revenues Revenues	18799000	USD
CY2015Q2	us-gaap	Revenues Revenues	19516000	USD
CY2015Q3	us-gaap	Revenues Revenues	19972000	USD
CY2015Q4	us-gaap	Revenues Revenues	18035000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	9232000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	11102000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	11521000	USD
CY2015Q4	us-gaap	Costs And Expenses CostsAndExpenses	11767000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9567000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	8414000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8451000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	6268000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4369000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3571000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4559000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2876000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2014Q1	us-gaap	Revenues Revenues	10899000	USD
CY2014Q2	us-gaap	Revenues Revenues	6647000	USD
CY2014Q3	us-gaap	Revenues Revenues	17387000	USD
CY2014Q4	us-gaap	Revenues Revenues	21037000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	7404000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	9107000	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	9188000	USD
CY2014Q4	us-gaap	Costs And Expenses CostsAndExpenses	10265000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3495000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2460000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	8199000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	10772000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3359000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2363000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	6746000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21005000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3307000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4151000	USD
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	18198000	USD
CY2013Q2	anip	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash	2260000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	10900000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	79000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Assets Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsNoncurrent	0	USD
CY2013Q2	us-gaap	Goodwill Goodwill	1838000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	33275000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.053	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2013Q2	anip	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Severance BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedSeverance	2965000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	515000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	3480000	USD
CY2013Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	29795000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1271000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	618000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	504000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	30228000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	89000	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	0	USD
CY2014Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16700000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	500000	shares
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2000000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4400000	USD
CY2014	anip	Options Previously Granted Approved By Share Holders OptionsPreviouslyGrantedApprovedByShareHolders	300000	shares
CY2013	us-gaap	Depreciation Depreciation	500000	USD
CY2014	us-gaap	Depreciation Depreciation	600000	USD
CY2015	us-gaap	Depreciation Depreciation	700000	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	195000	USD
CY2014Q1	anip	Intangible Asset Purchase Agreement Payment IntangibleAssetPurchaseAgreementPayment	8500000	USD
CY2015	anip	Monitoring And Advisory Fee MonitoringAndAdvisoryFee	500000	USD
CY2013	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6200000	USD
CY2013Q2	us-gaap	Share Price SharePrice	1.22
CY2013Q2	anip	Business Combination Cost Of Acquired Entity Purchase Price BusinessCombinationCostOfAcquiredEntityPurchasePrice	29800000	USD
CY2015Q4	anip	Business Combination Deferred Tax Assets Established Gross BusinessCombinationDeferredTaxAssetsEstablishedGross	9600000	USD
CY2015Q4	anip	Business Combination Deferred Tax Liabilities Established Gross BusinessCombinationDeferredTaxLiabilitiesEstablishedGross	3900000	USD
CY2015Q4	anip	Business Combination Deferred Tax Asset Liability Valuation Allowance Established BusinessCombinationDeferredTaxAssetLiabilityValuationAllowanceEstablished	5700000	USD
CY2015Q4	anip	Business Combination Purchase Price Allocation Deferred Tax Assets Net BusinessCombinationPurchasePriceAllocationDeferredTaxAssetsNet	0	USD

Files In Submission

Name	View Source	Status
0001144204-16-083848-index-headers.html	Edgar Link	pending
0001144204-16-083848-index.html	Edgar Link	pending
0001144204-16-083848.txt	Edgar Link	pending
0001144204-16-083848-xbrl.zip	Edgar Link	pending
anip-20151231.xml	Edgar Link	completed
anip-20151231.xsd	Edgar Link	pending
anip-20151231_cal.xml	Edgar Link	unprocessable
anip-20151231_def.xml	Edgar Link	unprocessable
anip-20151231_lab.xml	Edgar Link	unprocessable
anip-20151231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg38log.jpg	Edgar Link	pending
v430573_10k.htm	Edgar Link	pending
v430573_ex21.htm	Edgar Link	pending
v430573_ex23-1.htm	Edgar Link	pending
v430573_ex31-1.htm	Edgar Link	pending
v430573_ex31-2.htm	Edgar Link	pending
v430573_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANIP
ANI Pharmaceuticals Inc Stock $anip

2015 Q4 Form 10-K Financial Statement

#000114420416083848 Filed on February 23, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANIP ANI Pharmaceuticals Inc Stock $anip

2015 Q4 Form 10-K Financial Statement

#000114420416083848 Filed on February 23, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANIP
ANI Pharmaceuticals Inc Stock $anip